Literature DB >> 16740751

Quantitative multiplex methylation-specific PCR analysis doubles detection of tumor cells in breast ductal fluid.

Mary Jo Fackler1, Kara Malone, Zhe Zhang, Eric Schilling, Elizabeth Garrett-Mayer, Theresa Swift-Scanlan, Julie Lange, Ritu Nayar, Nancy E Davidson, Seema A Khan, Saraswati Sukumar.   

Abstract

PURPOSE: The challenges of cytology for accurate diagnosis of breast cancer are well recognized. We previously showed that normal and tumor tissue can be distinguished using a technique called quantitative multiplex methylation-specific PCR (QM-MSP). We hypothesized that quantitative analysis of methylated genes will provide enhanced detection of cancer cells present in cytologic specimens. EXPERIMENTAL
DESIGN: QM-MSP was done on ductal lavage cells from a set of 37 ductal lavage samples from women undergoing mastectomy (27 with cancer and 3 without). Duct histology information was available for each lavaged duct. QM-MSP data was assessed by measuring cumulative methylation index and by receiver operating characteristic threshold analysis. To determine the baseline level of methylation for each gene in this population, cells from 60 ducts of women at high risk of developing breast cancer were analyzed.
RESULTS: QM-MSP findings on a panel of nine genes were correlated to duct histology and ductal lavage cytology. Cytology detected cancer in 33% (7 of 21 ducts) with a specificity of 99% (92 of 93). QM-MSP detected cancer as calculated by cumulative methylation index with a sensitivity of 62% (13 of 21) and specificity of 82% (62 of 76) and by receiver operating characteristic threshold analysis with a sensitivity of 71% (15 of 21) and specificity of 83% (63 of 76).
CONCLUSIONS: Compared with cytology, QM-MSP doubled the sensitivity of detection of cancer. This study provides proof of principle by showing the advantages of using methylation analyses to query cytologic specimens and indicates its potential use in diagnosis and in stratifying risk.

Entities:  

Mesh:

Year:  2006        PMID: 16740751     DOI: 10.1158/1078-0432.CCR-05-2733

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  50 in total

Review 1.  The epigenetics of breast cancer.

Authors:  Jovana Jovanovic; Jo Anders Rønneberg; Jörg Tost; Vessela Kristensen
Journal:  Mol Oncol       Date:  2010-04-29       Impact factor: 6.603

2.  Basal-like breast cancer displays distinct patterns of promoter methylation.

Authors:  Ji Shin Lee; Mary Jo Fackler; Jae Hyuk Lee; Chan Choi; Min Ho Park; Jung Han Yoon; Zhe Zhang; Saraswati Sukumar
Journal:  Cancer Biol Ther       Date:  2010-06-18       Impact factor: 4.742

Review 3.  Epigenetic alterations in the breast: Implications for breast cancer detection, prognosis and treatment.

Authors:  Amy M Dworkin; Tim H-M Huang; Amanda Ewart Toland
Journal:  Semin Cancer Biol       Date:  2009-02-20       Impact factor: 15.707

4.  Analysis of DNA methylation of multiple genes in microdissected cells from formalin-fixed and paraffin-embedded tissues.

Authors:  Dimo Dietrich; Ralf Lesche; Reimo Tetzner; Manuel Krispin; Jörn Dietrich; Wolfgang Haedicke; Matthias Schuster; Glen Kristiansen
Journal:  J Histochem Cytochem       Date:  2009-01-19       Impact factor: 2.479

5.  MethySYBR, a novel quantitative PCR assay for the dual analysis of DNA methylation and CpG methylation density.

Authors:  Pang-Kuo Lo; Hanano Watanabe; Pi-Chun Cheng; Wei Wen Teo; Xiaohui Liang; Pedram Argani; Ji Shin Lee; Saraswati Sukumar
Journal:  J Mol Diagn       Date:  2009-09       Impact factor: 5.568

6.  MGMT promoter methylation in serum and cerebrospinal fluid as a tumor-specific biomarker of glioma.

Authors:  Zheng Wang; Wei Jiang; Yahong Wang; Yang Guo; Zheng Cong; Fangfang DU; Bin Song
Journal:  Biomed Rep       Date:  2015-05-13

Review 7.  Epigenomics and breast cancer.

Authors:  Pang-Kuo Lo; Saraswati Sukumar
Journal:  Pharmacogenomics       Date:  2008-12       Impact factor: 2.533

8.  Aberrant gene methylation in the peritoneal fluid is a risk factor predicting peritoneal recurrence in gastric cancer.

Authors:  Masatsugu Hiraki; Yoshihiko Kitajima; Seiji Sato; Jun Nakamura; Kazuyoshi Hashiguchi; Hirokazu Noshiro; Kohji Miyazaki
Journal:  World J Gastroenterol       Date:  2010-01-21       Impact factor: 5.742

9.  Heterogeneity of breast cancer metastases: comparison of therapeutic target expression and promoter methylation between primary tumors and their multifocal metastases.

Authors:  Julie M Wu; Mary Jo Fackler; Marc K Halushka; Diana W Molavi; M Evangeline Taylor; Wei Wen Teo; Constance Griffin; John Fetting; Nancy E Davidson; Angelo M De Marzo; Jessica L Hicks; Dhananjay Chitale; Marc Ladanyi; Saraswati Sukumar; Pedram Argani
Journal:  Clin Cancer Res       Date:  2008-04-01       Impact factor: 12.531

10.  Methylation of homeobox genes is a frequent and early epigenetic event in breast cancer.

Authors:  Stella Tommasi; Deborah L Karm; Xiwei Wu; Yun Yen; Gerd P Pfeifer
Journal:  Breast Cancer Res       Date:  2009-02-27       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.